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Abstract3
4
This study explored public perceptions about the importance of, and how to create, ageing-5
and dementia-friendly pharmacists and pharmacies. In September 2016, four focus groups6
(45 minutes each) were conducted with sixteen participants who represented organisations,7
groups or forums working with and/or for older people and people with dementia in8
Greater London. Discussions were recorded via hand-written notes and thematically9
analysed. Participants confirmed the importance of pharmacists and pharmacies being10
ageing- and dementia-friendly and described variability in whether this is currently the case.11
Suggested strategies for improvement included targeting communication, pharmacist12
leadership and shop layout.13
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Introduction21
22
Consumers, policy makers and researchers world-wide have become increasingly interested23
in the concept and development of dementia-friendly communities (Alzheimer's Disease24
2International). A dementia-friendly community is defined by the Alzheimer’s Society as25
‘supportive and inclusive of people affected by dementia’ (Alzheimer’s Society) and by26
Alzheimer’s Australia as ‘a place where people living with dementia are supported to live a27
high quality of life with meaning, purpose and value’ (Alzheimer's Australia, 2017). A priority28
area in creating dementia-friendly communities is access to appropriate healthcare services,29
to support people with dementia to live at home for as long as possible (Alzheimer's30
Australia, 2017).31
32
Pharmacies are important places that people with dementia visit (Brorsson, Ohman,33
Lundberg, & Nygard, 2011). People with dementia are prescribed multiple medications34
(Schubert et al., 2006) and they consider pharmacists as crucial to their medication35
management team (While, Duane, Beanland, & Koch, 2012). As a result, pharmacies should36
be ageing- and dementia-friendly (Bennett, 2015). The Alzheimer’s Society (Alzheimer’s37
Society, 2015) and Alzheimer’s Australia (Alzheimer's Australia, 2017) have developed38
toolkits to support businesses in the pursuit of becoming dementia-friendly, with39
suggestions including: pharmacists should identify specific medication needs of local people40
with dementia and their carers, to ensure tailored, person-centred pharmacy services; staff41
should be trained in dementia-appropriate communication; and the pharmacy workplace42
environment should be assessed for adequate signage, lighting, colour contrast, labelling43
and quiet areas (Alzheimer's Australia, 2017; Alzheimer’s Society, 2015; Stafford, 2015).44
45
This study aimed to explore the perceptions of individuals who represent organisations that46
work with and/or for older people and people with dementia, regarding the importance of47
ageing- and dementia-friendly pharmacists and pharmacies, and how they can be created.48
349
Methods50
51
In September 2016, JG-T presented a public seminar at the Age UK London’s offices52
concerning her Australian ageing- and dementia-related research. All individuals on the Age53
UK London’s offices electronic mailing list were invited to attend. These individuals54
represented at least 500 organisations, ranging from small, local clubs to large forums with55
over 1000 members, working with and/or for older people and people with dementia in56
Greater London. The first 20 interested individuals were registered to attend. Immediately57
after the public seminar, JG-T invited all attendees to participate in a focus group. A study58
explanatory statement was provided and a signed consent form was required. Seminar59
attendees were invited to participate in this study as their work roles increased the60
likelihood that they could knowledgeably contribute to the study.61
62
It was anticipated that all 20 public seminar attendees would participate in the study,63
leading to a total of four focus groups with five participants each. The total number and size64
of focus groups was chosen to ensure all relevant issues would be identified without new65
ideas emerging (Smith, 2002) and that all participants could contribute to discussions66
(Krueger, 1994; Smith, 2002). Each focus group was moderated by one of four facilitators67
(including JG-T). This allowed multiple focus groups to be conducted simultaneously, after68
the public seminar had concluded, at the Age UK London’s offices. All facilitators had69
experience undertaking qualitative research, were appropriately skilled to guide discussions70
without influencing them and to ensure equal participant contributions, and three of them71
were pharmacists (Patton, 1990).72
473
To maintain anonymity, and as per the study ethical approval, participant names were not74
used during discussions, audio-recording was not possible and identifying information could75
not be recorded. Each facilitator used hand-written notes to record the main focus group76
discussion points and participants had the opportunity to assist the facilitator in ensuring77
that their contributions were accurately recorded. This methodology has been78
recommended in circumstances where audio-recording is not possible (Kitzinger, 1995). This79
study followed similar, successful methodology where public engagement has informed80
priorities in health and social care research and practice (Alsaeed et al., 2016; Poland et al.,81
2014).82
83
An open-ended, semi-structured question guide (McNeill & Chapman, 2005) was developed84
by JG-T (Table 1) to allow participants to raise new ideas or issues that they believed were85
important, which focus group facilitators could further explore by asking additional86
questions (Smith, 2002). Communicative validity was assessed in this study by comparing87
study findings with existing dementia-friendly community guidelines (Alzheimer's Australia,88
2017; Alzheimer’s Society, 2015; Smith, 2002).89
90
Table 1. Semi-structured question guide91
Number Question
1 What makes a health care environment/health care professional ageing- or
dementia-friendly?
2 How important is it that pharmacies/pharmacists are ageing- and dementia-
5friendly?
3 Do you perceive that pharmacies/pharmacists are ageing- and dementia-friendly
currently (and describe how they are or are not)?
4 What are your recommendations to make pharmacies/pharmacists more ageing-
and dementia-friendly?
5 How should we be educating our pharmacy students/health care professional
students to be more ageing- and dementia-friendly?
92
Ethical approval93
94
As JG-T was based at Monash University (Australia), ethical approval was obtained from the95
Monash University Human Research Ethics Committee (Project Number: 0742). This ethical96
approval allowed JG-T to conduct the study in the UK.97
98
Data analysis99
100
Data were analysed using a thematic approach, which involved familiarisation with the raw101
data, identification of key themes as they emerged, defining and naming themes, formation102
of an initial coding frame, and indexation of the data to that coding frame (Pope, Ziebland,103
& Mays, 2000). The coding frame was discussed among all four focus group facilitators to104
ensure the validity and credibility of data analysis and to clarify discrepancies.105
106
Results107
108
6Four focus groups, of approximately 45 minute duration, were conducted with a total of 16109
participants (only 16 of the 20 public seminar registrants actually attended the public110
seminar). The seven male and nine female participants were representatives of111
organisations, groups or forums working with and/or for older people and people with112
dementia in Greater London. Participant work roles ranged from positions of leadership to113
lay members and volunteers. Many participants were aged older than 55 years and used114
their and their members’ personal experiences to inform discussions. According to the115
ethical approval of the study, specific participant characteristics were not recorded.116
Identified themes are presented below in italics.117
118
The importance of ageing- and dementia-friendly pharmacists and pharmacies.119
120
Participants explained that as the population is ageing and the number of people with121
dementia is increasing, there is an increase in healthcare being provided in the community122
setting, and pharmacies are community-based healthcare destinations that are accessible to123
older people and people with dementia. However, they explained that there does not124
appear to be a satisfactory ageing- and dementia-friendly standard being adhered to by125
pharmacists and pharmacies. Participants mentioned that it could be more difficult for126
pharmacies to be ageing- and dementia-friendly if they were part of large organisations,127
compared to smaller, independent pharmacies, where staff could be more familiar with the128
community they serviced.129
130
Strategies to improve how ageing- and dementia-friendly pharmacists are.131
132
7Participants suggested that when communicating, pharmacists should: allow people with133
dementia adequate time to communicate without feeling rushed; use eye contact; be calm,134
patient and respectful; physically approach patients from behind pharmacy barriers; and135
consider writing important information down for the patient where necessary. Participants136
suggested that pharmacists could ask general practitioners to help them identify patients137
with dementia, so that a dementia register could be developed and more individualised138
services provided. However, pharmacists would need to be aware of the risk of stereotyping139
or labelling people with dementia. It was suggested that pharmacists could also adopt a140
leadership role in providing ageing- and dementia-friendly services and encourage other141
pharmacists to also take on this role. When referring to healthcare professionals in general,142
participants suggested that they should adopt a positive ageing- and dementia-friendly143
attitude and that dementia-friendly terminology should be used when communicating144
about dementia (e.g. ‘living’, compared to ‘suffering’ from dementia).145
146
Strategies to improve how ageing- and dementia-friendly pharmacies are.147
148
Participants recommended that: pharmacies are easily identifiable and accessible if they are149
located within large shops; signage should be clear and limited in number; there should be150
seating, a private consultation room and a hearing loop system; door mats should not be151
black; and a clear and concise list of what pharmacies do or do not do should be present, as152
well as information regarding where older people can access healthcare services. It was153
recommended that pharmacies adopt ageing- and dementia-friendly standards, which are154
developed in conjunction with people with dementia and their carers. Additionally,155
pharmacies should be regularly assessed for dementia-friendliness (e.g. using mystery156
8shoppers) and provided with a dementia-friendly rating or clear signage that identifies them157
as dementia-friendly.158
159
Strategies to improve how ageing- and dementia-friendly healthcare professional students160
are.161
162
Participants recommended that students should undertake work experience in different163
settings (care homes, hospitals, pharmacies, dementia cafes, memory clinics, day care164
centres) where they may encounter older people and people with dementia. Additionally,165
students could be asked to explore the experiences they’ve had with their grandparents or166
become friends with older people. Participants explained that the ageing- and dementia-167
friendly theme should be incorporated throughout all years of the educational program, it168
should be compulsory for students to attend ageing- and dementia-related topics, and169
relevant topics could be taught by older people and people with dementia. Participants felt170
that students should understand that older people and people with dementia differ in terms171
of their characteristics and needs and that ageing does not always lead to cognitive172
impairment or dementia.173
174
Conclusion175
176
This study has provided important insight into public perception of the importance of177
developing community pharmacies as dementia-friendly environments. Participant178
suggestions of how to develop dementia-friendly pharmacies were similar to those in179
Alzheimer’s Society and Alzheimer’s Australia guidelines (Alzheimer's Australia, 2017;180
9Alzheimer’s Society, 2015) including, clear signage, considering the input of people with181
dementia when designing dementia-friendly environments, and using dementia appropriate182
language (Swaffer, 2014). With regards to the suggestion of a dementia register, increasing183
pharmacist awareness of patients with dementia may instead be addressed by the current184
National Health Service (NHS) initiative to allow community pharmacists to view Summary185
Care Records (SCR) (NHS Digital, 2017a, 2017b). These patient-specific electronic records are186
created from general practitioner medical records, must contain certain patient information187
(e.g. current medications), and may contain other information if the patient wishes (e.g.188
chronic medical conditions, such as dementia) (NHS Digital, 2017a, 2017b). Pharmacists can189
view SCR if they are involved in the patient’s care and have their consent (NHS Digital,190
2017a, 2017b). Pharmacist-accessible SCR could address potential issues associated with191
developing a pharmacy-based dementia register, such as not having a regular pharmacist to192
whom details of the person with dementia could be sent, the need for a general practitioner193
to obtain consent before disclosing medical details about a specific patient, and the194
difficulties associated with establishing comprehensive data protection policies and195
practices. In terms of policy, practice and research implications: the Alzheimer’s Society and196
Alzheimer’s Australia should collaborate with pharmacy organisations like the Royal197
Pharmaceutical Society of Great Britain and Pharmaceutical Society of Australia, to198
determine how best to support the implementation of available guidelines (Alzheimer's199
Australia, 2017; Alzheimer’s Society, 2015); pharmacists should explore local logistical,200
organisational, financial and personal barriers and facilitators to guideline implementation;201
and future research should comprehensively explore whether ageing- and dementia-friendly202
strategies are currently being implemented into pharmacies.203
204
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